CD4+CD25- T cells that express latency-associated peptide on the surface suppress CD4+CD45RBhigh-induced colitis by a TGF-β-dependent mechanism

Journal of Immunology

Volumn 170, Issue 5, 2003, Pages 2516-2522

  Oida, Takatoku ^a   Zhang, Xingmin ^a   Goto, Masao ^b,c   Hachimura, Satoshi ^b   Totsuka, Mamoru ^b   Kaminogawa, Shuichi ^b   Weiner, Howard L ^a,d  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF TOKYO   (Japan)

^c NATIONAL FOOD RESEARCH INSTITUTE   (Japan)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD45 ANTIGEN; INTERLEUKIN 2 RECEPTOR; LATENCY ASSOCIATED PEPTIDE; PEPTIDE; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL FRACTIONATION; CELL FUNCTION; CELL ISOLATION; COLITIS; CONTROLLED STUDY; FEMALE; LYMPHOCYTE SUBPOPULATION; MALE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STAINING;

EID: 0037371301     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.170.5.2516     Document Type: Article

References (38)

1. + naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state. Int. Immunol. 10:1969.
2. + immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J. Exp. Med. 188:287.
3. + T cells. J. Exp. Med. 183:2669.
4. + regulatory cells that control intestinal inflammation. J. Exp. Med. 192:295.
5. Asseman, C., S. Mauze, M. W. Leach, R. L. Coffman, and F. Powrie. 1999. An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. J. Exp. Med. 190:995.
6. Zuany-Amorim, C., E. Sawicka, C. Manlius, A. Le Moine, L. R. Brunet, D. M. Kemeny, G. Bowen, G. Rook, and C. Walker. 2002. Suppression of airway eosinophilia by killed Mycobacterium vaccae-induced allergen-specific regulatory T-cells. Nat. Med. 8:625.
7. + regulatory T cells by oral antigen administration. J. Immunol. 167:4245.
8. + human thymocytes. J. Exp. Med. 196:379.
9. + regulatory T cells can mediate suppressor function in the absence of transforming growth factor β1 production and responsiveness. J. Exp. Med. 196:237.
10. + regulatory T cells is mediated by cell surface-bound transforming growth factor β. J. Exp. Med. 194:629.
11. Miyazono, K., H. Ichijo, and C. H. Heldin. 1993. Transforming growth factor-β: latent forms, binding proteins and receptors. Growth Factors 8:11.
12. + T cells regulate the expansion of peripheral CD4 T cells through the production of IL-10. J. Immunol. 166:3008.
13. + T cells in autoimmune diabetes. Nat. Immunol. 2:1117.
14. - subpopulations. J. Immunol. 165:3105.
15. - regulatory cells mediate dominant transplantation tolerance. J. Immunol. 168:5558.
16. + T cells induced by donor dendritic cells in allograft tolerance by LF15-0195 treatment. J. Immunol. 168:5058.
17. + T cells induce or protect from chronic intestinal inflammation in C.B-17 scid mice. Int. Immunol. 5:1461.
18. Schultz-Cherry, S., S. Ribeiro, L. Gentry, and J. E. Murphy-Ullrich. 1994. Thrombospondin binds and activates the small and large forms of latent transforming growth factor-β in a chemically defined system. J. Biol. Chem. 269:26775.
19. Yehualaeshet, T., R. O'Connor, J. Green-Johnson, S. Mai, R. Silverstein, J. E. Murphy-Ullrich, and N. Khalil. 1999. Activation of rat alveolar macrophage-derived latent transforming growth factor β-1 by plasmin requires interaction with thrombospondin-1 and its cell surface receptor, CD36. Am. J. Pathol. 155:841.
20. Asselin-Paturel, C., A. Boonstra, M. Dalod, I. Durand, N. Yessaad, C. Dezutter-Dambuyant, A. Vicari, A. O'Garra, C. Biron, F. Briere, et al. 2001. Mouse type 1 IFN-producing cells are immature APCs with plasmacytoid morphology. Nat. Immunol. 2:1144.
21. Bjorck, P. 2001. Isolation and characterization of plasmacytoid dendritic cells from Flt3 ligand and granulocyte-macrophage colony-stimulating factor-treated mice. Blood 98:3520.
22. - dendritic cells. Eur. J. Immunol. 31:3403.
23. + cells in mouse lymph nodes and spleen display characteristics of plasmacytoid dendritic cells. J. Exp. Med. 194:1171.
24. + regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J. Exp. Med. 192:303.
25. Liu, Y. J., H. Kanzler, V. Soumelis, and M. Gilliet. 2001. Dendritic cell lineage, plasticity and cross-regulation. Nat. Immunol. 2:585.
26. 3, and integrin-associated protein. Biochem. Biophys. Res. Commun. 284:11.
27. Poczatek, M. H., C. Hugo, V. Darley-Usmar, and J. E. Murphy-Ullrich. 2000. Glucose stimulation of transforming growth factor-β bioactivity in mesangial cells is mediated by thrombospondin-1. Am. J. Pathol. 157:1353.
28. Crawford, S. E., V. Stellmach, J. E. Murphy-Ullrich, S. M. Ribeiro, J. Lawler, R. O. Hynes, G. P. Boivin, and N. Bouck. 1998. Thrombospondin-1 is a major activator of TGF-β1 in vivo. Cell 93:1159.
29. Ribeiro, S. M., M. Poczatek, S. Schultz-Cherry, M. Villain, and J. E. Murphy-Ullrich. 1999. The activation sequence of thrombospondin-1 interacts with the latency-associated peptide to regulate activation of latent transforming growth factor-β. J. Biol. Chem. 274:13586.
30. 7 (CD103). Immunology 103:146.
31. + suppressor T cells in vivo. Nat. Immunol. 3:33.
32. Chen, Y., V. K. Kuchroo, J. Inobe, D. A. Hafter, and H. L. Weiner. 1994. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science 265:1237.
33. + T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 389:737.
34. Maloy, K. J., and F. Powrie. 2001. Regulatory T cells in the control of immune pathology. Nat. Immunol. 2:816.
35. Mujtaba, M. G., J. M. Soos, and H. M. Johnson. 1997. CD4 T suppressor cells mediate interferon τ protection against experimental allergic encephalomyelitis. J. Neuroimmunol. 75:35.
36. Cottrez, F., and H. Groux. 2001. Regulation of TGF-β response during T cell activation is modulated by IL-10. J. Immunol. 167:773.
37. Kitani, A., I. J. Fuss, K. Nakamura, O. M. Schwartz, T. Usui, and W. Strober. 2000. Treatment of experimental (trinitrobenzene sulfonic acid) colitis by intranasal administration of transforming growth factor (TGF)-β1 plasmid: TGF-β1-mediated suppression of T helper cell type I response occurs by interleukin (IL)-10 induction and IL-12 receptor β2 chain downregulation. J. Exp. Med. 192:41.
38. Fuss, I. J., M. Boirivant, B. Lacy, and W. Strober. 2002. The interrelated roles of TGF-β and IL-10 in the regulation of experimental colitis. J. Immunol. 168:900.